Press Releases

May 16, 2005 Alferon LDO Now in Human Clinical Trials As Experimental Antiviral/Immunodulatory Therapy

May 11, 2005 HEMISPHERX BIOPHARMA FIRST QUARTER 2005 EARNINGS ANNOUNCED

May 03, 2005 Chronic Fatigue Syndrome Presented at Symposium in New York

Apr 11, 2005 Hemispherx Biopharma's Investigational Drug Increases Physical Performance in New Chronic Fatigue Syndrome (CFS) Clinical Study

Mar 30, 2005 Hemispherx Biopharma to Present New Phase III Results in Chronic Fatigue Syndrome Treatment at 18th International Conference on Antiviral Research

Mar 21, 2005 Hemispherx Biopharma Inc. Appoints Steven D. Spence to the Board of Directors

Feb 24, 2005 Hemispherx Biopharma's Alferon N® Highlighted as Potential New Therapy for Avian Influenza on CNBC's "Closing Bell"

Feb 14, 2005 HEMISPHERX BIOPHARMA, INC. ELECTS PRESIDENT AND CHIEF OPERATING OFFICER

Feb 07, 2005 HEMISPHERX BIOPHARMA EXPANDS EVALUATION OF ALFERON N AGAINST AVIAN FLU

Jan 03, 2005 HEMISPHERX BIOPHARMA INITIATES ENROLLMENT IN HIV/HEP-C CLINICAL PROGRAM

54 55 56 57 58 59 60 61 62 63 64

<< < > >>